Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

2019-03-21
Price :
Published : Mar-2019
No. of Pages : 47

Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

Summary

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that results in the scarring of lung tissue and changes the lung’s ability to function normally. The most common signs and symptoms of idiopathic pulmonary fibrosis are dyspnea and a persistent nonproductive cough. Many affected individuals also experience a loss of appetite and gradual weight loss. IPF primarily occurs in older adults. However, the causes are unknown.

This report provides an assessment of the pipeline, clinical, and commercial landscape of IPF. Overall, GlobalData expects new drug approvals to drive IPF market growth over the next decade (2016-2026).

Scope

– Pipeline Assessment-regional breakdown, promising late-stage products, early-stage pipeline by molecule type
– Clinical Trials Assessment-trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
– Commercial Assessment-leading marketed products, current and future players
– Competitive Landscape Analysis-key market events (2016-2026).

Reasons to buy

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global IPF market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global IPF market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Filed in: Medical Device
Publisher : GlobalData
More Reports
Title Price Buy Now

Hematology Analyzers and Reagents Market by Products & Services [Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology], Price Range (High, Low), End User (Government labs) – Global Forecast to 2025

“The hematology analyzers and reagents market is projected to grow at a CAGR of 6.9%.” The global hematology analyzers and reagents market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%. Technological advancements in hematology analyzers and reagents, the integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent. “High-end hematology analyzers to be the fastest-growing segment during the forecast pe......
$4950

Refurbished Medical Equipment Market by Product (Medical Imaging, Intensive Care Equipment, OR Equipment, Patient Monitors), Application (Cardiology, Neurology, Urology, Oncology), End User (Hospitals, Diagnostic Imaging Centers)-Global Forecasts to 2025

 “The global refurbished medical equipment market is projected to grow at a CAGR of 11.8%.” The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025.The growth of the global refurbished medical equipment market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devises, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies. However, factors such as stringent regulations o......
$4950

European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) – Forecast to 2025

“The European Medical Device market is projected to grow at a CAGR of 4.7 % between 2020 and 2025.” The European medical devices market is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period. Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. “Orthopedic device segment to have the largest share during the forecast period.” The ort......
$5650

Centesis Catheters Market by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region – Global Forecast to 2025

“Global centesis catheters market is projected to grow at a CAGR of 6.8%” The global centesis catheters market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, growing at a CAGR of 6.8% from 2019 to 2025. The key factors driving the growth of this market include the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases. However, premium product pricing and medical complexities associated with centesis procedures are some of the major factors that are expected to restrain the growth of this market in the coming years. “Small-bore centesis catheters seg......
$5650

Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User, Region-Global Forecast to 2025

“The global veterinary point-of-care diagnostics market is projected to grow at a CAGR of 8.9% during the forecast year.” The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%. The increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for rapid disease detection are the major factors driving the growth of this market. However, the high cost of veterinary imaging instruments is expected to restrain market growth to a certain extent. “The consumables segment dominates the veterinary point-of-care diagnostics market.” Based on product, the veterinary point-of-care diagnostics market is segmented into consumables and instruments. C......
$5650

Veterinary Monitoring Equipment Market by Type (Vital Signs Monitor, Anesthesia Monitor, ECG Monitor), Target Area (Respiratory diseases, Weight Monitoring), Animal Type (Dogs, Cats, Equines), End User (Veterinary Clinic), Region – Global Forecast to 2025

“The veterinary monitoring equipment market is projected to grow at a CAGR of 9.8% during the forecast period (2019–2025).” The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%. The increasing focus on animal health among pet owners and the growing prevalence of diseases among companion animals are the key factors driving market growth. Also, the growing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the rising number of veterinary practitioners & income levels in developed economies are aiding the adoption of veterinary monitoring equipment. “The vital sign monitors segment is expected to grow at the highest rate during the forecast pe......
$5650

Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) – Global Forecast to 2025

“The medical wearables market is expected to grow at a CAGR of 21.4% during the forecast period.” The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population and rising focus on patient-centric healthcare delivery. “Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019.” In 2019, the vital signs monitoring segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growing use of high-tech devices, which are compact, user-fri......
$5650

Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region – Global Forecast to 2025

“The ostomy care market projected to grow at a CAGR of 4.4% over the forecast period of 2020-2025.” The ostomy care market is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Globally, the population of individuals aged 60 years and above is expected to increase from 962 million in 2017 to 2.1 billion by 2050 (Source: UN Population Division). The rising geriatric population is considered as one of the major factors driving the growth of the ostomy care industry, as the incidence of bladder cancer and colorectal cancer is high among geriatric individuals. Thus, the rising geriatric population, coupled withthe growing number of awareness programs to educate patients regarding the use of ostomy products,are the major......
$6780

Healthcare / Medical Simulation Market by Product & Services (Patient Simulator, Task Trainer, Surgical Simulator (Laparoscopy, Arthroscopy), Dental Simulator, Eye Simulator, Ultrasound Simulator, Simulation Software), End User – Global Forecast to 2025

“The medical simulation market is projected to grow at a CAGR of 14.6% between 2020 and 2025.” The global medical simulation market size is expected to reach USD 3.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 14.6% from 2020 to 2025. The limited access to live patients during training, advancements in medical education, increasing demand for minimally invasive treatments, increasing focus on patient safety, and growing demand for virtual training due to current COVID-19 pandemic are the major factors driving the growth of the medical simulation industry. Moreover, factors such as increasing awareness about simulation education in emerging countries and shortage of healthcare personnel are creating lucrative opportunities for the market players. “Laparoscopic sur......
$4950

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region – Global Forecast to 2025

“The microfluidics market is projected to grow at a CAGR of 22.9%.” The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period. The ability of the microfluidics technology to replicate all the functions of its traditional counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) diagnostics, and clinical diagnostics, is resulting in its wider adoption across the globe. In addition to this, technological advancements, increasing focus on data precision & accuracy, fast returns on investment, and faster testing & improved portability through microfluidic chip miniaturization are driving growth of the microfluidics industry. “In 2019, in-v......
$4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy